Prenetics Global (PRE)
(Delayed Data from NSDQ)
$4.61 USD
-0.36 (-7.24%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.62 +0.01 (0.22%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Prenetics Global Limited falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 62 | 167 | 0 | -99,999 | -99,999 |
Receivables | 4 | 42 | 0 | NA | NA |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | 3 | 5 | 0 | NA | NA |
Other Current Assets | 25 | 29 | 1 | NA | NA |
Total Current Assets | 94 | 242 | 1 | NA | NA |
Net Property & Equipment | 6 | 13 | 0 | NA | NA |
Investments & Advances | 108 | NA | 339 | NA | NA |
Other Non-Current Assets | NA | NA | 0 | NA | NA |
Deferred Charges | 4 | 7 | 0 | NA | NA |
Intangibles | 43 | 44 | 0 | NA | NA |
Deposits & Other Assets | 1 | 2 | 0 | NA | NA |
Total Assets | 254 | 308 | 340 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | 2 | 7 | 0 | NA | NA |
Current Portion Long-Term Debt | NA | NA | 0 | NA | NA |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | 8 | 16 | 3 | NA | NA |
Income Taxes Payable | 7 | 9 | 0 | NA | NA |
Other Current Liabilities | 21 | 23 | 0 | NA | NA |
Total Current Liabilities | 39 | 57 | 3 | NA | NA |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | 3 | 2 | 12 | NA | NA |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | NA | NA | 0 | NA | NA |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | 1 | 5 | 352 | NA | NA |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | 44 | 68 | 367 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | 0 | 0 | 0 | NA | NA |
Capital Surplus | NA | NA | 0 | NA | NA |
Retained Earnings | NA | 237 | -27 | NA | NA |
Other Equity | 210 | 3 | 0 | NA | NA |
Treasury Stock | NA | NA | 0 | NA | NA |
Total Shareholder's Equity | 210 | 240 | -27 | NA | NA |
Total Liabilities & Shareholder's Equity | 254 | 308 | 340 | NA | NA |
Total Common Equity | 100,209 | 100,239 | -27 | 0 | 0 |
Shares Outstanding | 9.10 | 9.10 | 2.90 | NA | NA |
Book Value Per Share | 11,012.00 | 11,015.28 | -9.33 | 0.00 | 0.00 |
Fiscal Year End for Prenetics Global Limited falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 62 | 71 | 177 | 186 |
Receivables | NA | 4 | 5 | 6 | 6 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | 3 | 3 | 4 | 3 |
Other Current Assets | NA | 25 | 26 | 28 | 29 |
Total Current Assets | NA | 94 | 105 | 215 | 224 |
Net Property & Equipment | NA | 6 | 9 | 10 | 12 |
Investments & Advances | NA | 108 | 109 | 1 | 1 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | 4 | 5 | 7 | 5 |
Intangibles | NA | 43 | 47 | 48 | 48 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 1 |
Total Assets | NA | 254 | 276 | 281 | 291 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 4 | 4 | 8 |
Current Portion Long-Term Debt | NA | NA | 0 | 0 | 0 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | 8 | 8 | 19 | 6 |
Income Taxes Payable | NA | 7 | 9 | 9 | 9 |
Other Current Liabilities | NA | 21 | 18 | 17 | 22 |
Total Current Liabilities | NA | 39 | 40 | 52 | 48 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 3 | 3 | 3 | 3 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 0 | 0 | 0 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 3 | 3 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | 44 | 48 | 61 | 58 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | NA | 0 | 0 | 0 |
Retained Earnings | NA | NA | 0 | 0 | 0 |
Other Equity | NA | 210 | 229 | 220 | 234 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 210 | 229 | 220 | 234 |
Total Liabilities & Shareholder's Equity | NA | 254 | 276 | 281 | 291 |
Total Common Equity | 0 | 100,209 | 229 | 220 | 234 |
Shares Outstanding | 9.10 | 9.10 | 9.10 | 9.10 | 9.10 |
Book Value Per Share | 0.00 | 11,012.00 | 25.14 | 24.20 | 25.66 |